DSpace Repository

Prevalance of sarcopenia according to decade

Show simple item record

dc.contributor.author Yazar, Tamer
dc.contributor.author Yazar, Hulya Olgun
dc.date.accessioned 2024-03-15T11:14:29Z
dc.date.available 2024-03-15T11:14:29Z
dc.date.issued 2019
dc.identifier.citation Yazar, T., Yazar, HO. (2019). Prevalance of sarcopenia according to decade. Clin. Nutr. ESPEN, 29, 137-141. https://doi.org/10.1016/j.clnesp.2018.11.005 en_US
dc.identifier.issn 2405-4577
dc.identifier.uri http://dx.doi.org/10.1016/j.clnesp.2018.11.005
dc.identifier.uri https://www.webofscience.com/wos/woscc/full-record/WOS:000456061800021
dc.identifier.uri http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4445
dc.description WoS Categories: Nutrition & Dietetics en_US
dc.description Web of Science Index: Emerging Sources Citation Index (ESCI) en_US
dc.description Research Areas: Nutrition & Dietetics en_US
dc.description.abstract Aim: Our study aimed to identify Skeletal Muscle Mass Index (SMMI) cut-off values for sarcopenia diagnosis in our population and determine the prevalance of sarcopenia, and to collect data about reducing the disease load. Method: The study was completed with 515 volunteers divided into groups based on ages of 18-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years and 80 years and older. All groups had SMMI, muscle strenght physical performance assessed, with sarcopenia diagnosis made using the European Working Group on Sarcopenia in Older People (EWGSOP) diagnostic criteria. Results: Together with advancing decades, there were significant reductions observed in SMMI, hand grip test (HGT) and 4-m walking test (4MWT) values. For females and males, the reduction in HGT and 4MWT values began after 50 years of age, while the reduction in SMMI began after 70 years for males and after 60 years for females. The prevalance of sarcopenia in the 40-49, 50-59, 60-69, 70-79 and 80 years plus age intervals were identified as 7%, 10.6%, 15.4%, 21.2% and 36.5%, respectively. Conclusion: Identification of sarcopenia prevalence in our population is important due to limitations of treatment administered after diagnosis is made. (C) 2018 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved. en_US
dc.language.iso eng en_US
dc.publisher ELSEVIER SCIENCE BV-AMSTERDAM en_US
dc.relation.isversionof 10.1016/j.clnesp.2018.11.005 en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Sarcopenia, Skeletal muscle mass index, Hand grip test, 4 m walking test en_US
dc.subject EWGSOP DEFINITION, BODY-COMPOSITION, PREVALENCE, EPIDEMIOLOGY, DIAGNOSIS, DYNAPENIA, ADULTS, SCALE, MASS en_US
dc.title Prevalance of sarcopenia according to decade en_US
dc.type article en_US
dc.relation.journal CLINICAL NUTRITION ESPEN en_US
dc.contributor.department Ordu Üniversitesi en_US
dc.contributor.authorID 0000-0003-3054-6613 en_US
dc.contributor.authorID 0000-0003-2768-6092 en_US
dc.identifier.volume 29 en_US
dc.identifier.startpage 137 en_US
dc.identifier.endpage 141 en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account